Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alise Reicin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Medical Research and Opinion|May 14, 2004
Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trialsNathaniel Katz, Diana B Rodgers, David Krupa, et al.
American Heart Journal|October 18, 2003
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development programMatthew R Weir, Rhoda S Sperling, Alise Reicin, et al.
Current Medical Research and Opinion|May 11, 2005
The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction painKerstin Malmstrom, Jennifer Ang, James R Fricke, et al.
Current Medical Research and Opinion|May 23, 2002
A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agentsBarry J Gertz, David Krupa, James A Bolognese, et al.
Gastroenterology|October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritisLoren Laine, Claire Bombardier, Christopher J Hawkey, et al.
Journal of Clinical Pharmacology|July 21, 2006
Dental impaction pain model as a potential tool to evaluate drugs with efficacy in neuropathic painKerstin Malmstrom, Paul Kotey, Megan McGratty, et al.
Gastroenterology|January 31, 2003
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useLoren Laine, Laurine G Connors, Alise Reicin, et al.
Advances in Therapy|November 6, 2010
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesicsHao Wang, Cynthia Gargano, Suzanne Lukac, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosteroneShalender Bhasin, E Jiaxiu He, Miwa Kawakubo, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Evaluation of early biomarkers of muscle anabolic response to testosteroneFabian Chen, Raymond Lam, David Shaywitz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medical Research and Opinion|May 14, 2004
Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trialsNathaniel Katz, Diana B Rodgers, David Krupa, et al.
American Heart Journal|October 18, 2003
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development programMatthew R Weir, Rhoda S Sperling, Alise Reicin, et al.
Current Medical Research and Opinion|May 11, 2005
The analgesic effect of etoricoxib relative to that of cetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction painKerstin Malmstrom, Jennifer Ang, James R Fricke, et al.
Current Medical Research and Opinion|May 23, 2002
A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agentsBarry J Gertz, David Krupa, James A Bolognese, et al.
Gastroenterology|October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritisLoren Laine, Claire Bombardier, Christopher J Hawkey, et al.
Journal of Clinical Pharmacology|July 21, 2006
Dental impaction pain model as a potential tool to evaluate drugs with efficacy in neuropathic painKerstin Malmstrom, Paul Kotey, Megan McGratty, et al.
Gastroenterology|January 31, 2003
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useLoren Laine, Laurine G Connors, Alise Reicin, et al.
Advances in Therapy|November 6, 2010
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesicsHao Wang, Cynthia Gargano, Suzanne Lukac, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosteroneShalender Bhasin, E Jiaxiu He, Miwa Kawakubo, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Evaluation of early biomarkers of muscle anabolic response to testosteroneFabian Chen, Raymond Lam, David Shaywitz, et al.
Pageof 1